These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of providing feedback on inhaler technique and adherence from an electronic audio recording device, INCA®, in a community pharmacy setting: study protocol for a randomised controlled trial. O'Dwyer SM; MacHale E; Sulaiman I; Holmes M; Hughes C; D'Arcy S; Rapcan V; Taylor T; Boland F; Bosnic-Anticevich S; Reilly RB; Ryder SA; Costello RW Trials; 2016 May; 17(1):226. PubMed ID: 27142873 [TBL] [Abstract][Full Text] [Related]
4. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study. Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409 [TBL] [Abstract][Full Text] [Related]
5. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD. Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137 [TBL] [Abstract][Full Text] [Related]
7. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Nannini L; Cates CJ; Lasserson TJ; Poole P Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502 [TBL] [Abstract][Full Text] [Related]
8. A quantitative evaluation of adherence and inhalation technique among respiratory patients: An observational study using an electronic inhaler assessment device. Hesso I; Nabhani Gebara S; Greene G; Co Stello RW; Kayyali R Int J Clin Pract; 2020 Feb; 74(2):e13437. PubMed ID: 31621983 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients. Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143 [TBL] [Abstract][Full Text] [Related]
10. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Nannini L; Lasserson TJ; Poole P Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994 [TBL] [Abstract][Full Text] [Related]
11. Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. Ngo CQ; Phan DM; Vu GV; Dao PN; Phan PT; Chu HT; Nguyen LH; Vu GT; Ha GH; Tran TH; Tran BX; Latkin CA; Ho CSH; Ho RCM Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634631 [TBL] [Abstract][Full Text] [Related]
12. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. Zhang S; King D; Rosen VM; Ismaila AS Int J Chron Obstruct Pulmon Dis; 2020; 15():417-438. PubMed ID: 32161454 [TBL] [Abstract][Full Text] [Related]
13. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study). Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551 [TBL] [Abstract][Full Text] [Related]
14. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268 [TBL] [Abstract][Full Text] [Related]
15. Does device matter for inhaled therapies in advanced chronic obstructive pulmonary disease (COPD)? A comparative trial of two devices. Mannan H; Foo SW; Cochrane B BMC Res Notes; 2019 Feb; 12(1):94. PubMed ID: 30786914 [TBL] [Abstract][Full Text] [Related]
16. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler versus a multi-dose inhaler in patients with chronic obstructive pulmonary disease. Chan R; Sousa AR; Hynds P; Homayoun-Valiani F; Edwards D; Tabberer M Pulm Pharmacol Ther; 2017 Apr; 43():12-19. PubMed ID: 28115223 [TBL] [Abstract][Full Text] [Related]
18. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L; Forget A; Ramachandran S Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [TBL] [Abstract][Full Text] [Related]
19. Advances in Audio-Based Systems to Monitor Patient Adherence and Inhaler Drug Delivery. Taylor TE; Zigel Y; De Looze C; Sulaiman I; Costello RW; Reilly RB Chest; 2018 Mar; 153(3):710-722. PubMed ID: 28887061 [TBL] [Abstract][Full Text] [Related]
20. Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices. Melani AS; Paleari D COPD; 2016; 13(2):241-50. PubMed ID: 26407924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]